Can a urostomy, especially an ileal conduit or continent urinary reservoir, cause metabolic acidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Urostomy and Metabolic Acidosis

Yes, urostomy—particularly ileal conduit and continent urinary reservoirs—can cause hyperchloremic metabolic acidosis, with the risk being highest in patients with impaired renal function. This occurs through urinary reabsorption in the bowel segment, leading to chloride retention and bicarbonate loss 1, 2.

Mechanism of Acidosis

The ileal segment used in urinary diversion reabsorbs urine constituents, specifically:

  • Chloride is retained while bicarbonate is lost through exchange mechanisms in the ileal mucosa 1
  • This creates a non-anion gap (hyperchloremic) metabolic acidosis 3, 4
  • The longer urine remains in contact with the bowel segment, the greater the reabsorption and subsequent acidosis 1

Incidence and Risk Factors

Metabolic acidosis develops in 14-31% of patients within the first month after ileal conduit or neobladder creation 2. The key risk factor is:

  • Reduced estimated glomerular filtration rate (eGFR) is the strongest predictor of metabolic acidosis (OR = 0.94 per unit decrease in eGFR) 2
  • Acidosis risk is particularly elevated in patients with pre-existing renal impairment 1, 2
  • Improved urinary continence paradoxically increases acidosis risk in neobladder patients, as longer urine contact time with bowel allows greater reabsorption 5

Clinical Presentation

Patients may present with:

  • Anorexia and weight loss 1
  • Hypotension 1
  • Symptoms related to the underlying acidosis severity 3
  • Often asymptomatic in mild cases 1

Monitoring Requirements

Annual surveillance with basic metabolic panel is mandatory for all patients with bowel-based urinary reconstruction 6. More frequent monitoring is warranted:

  • During the first 3 months post-operatively, when continence is improving and acidosis risk peaks 5
  • In patients with baseline renal dysfunction 2
  • When clinical symptoms suggest metabolic derangement 1

Management

Sodium bicarbonate supplementation is the cornerstone of treatment 1, 4:

  • Oral sodium bicarbonate 2-4 g/day for chronic management 4
  • Intravenous bicarbonate for severe symptomatic acidosis 1
  • The need for bicarbonate replacement often increases over time (from 45% to 87% of patients during early recovery) 5

Maintain adequate hydration to prevent urinary stasis and excessive reabsorption 4. Dehydration exacerbates acidosis by prolonging urine contact time with the ileal segment 4.

Important Caveats

  • Ileal neobladders and ileal conduits carry similar acidosis risk—there is no significant difference in metabolic acidosis rates between these two diversion types 2
  • The acidosis is hyperchloremic (non-anion gap), which distinguishes it from other causes of metabolic acidosis and guides appropriate workup 3
  • Patients with urinary tract infections may experience worsened acidosis due to increased inflammation and altered absorption 3
  • Lifelong surveillance is required as complications can develop at any time post-operatively 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.